These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2846928)
21. Prognostic value of serum procollagen III peptide and type IV collagen in patients with biliary atresia. Kobayashi H; Miyano T; Horikoshi K; Tokita A J Pediatr Surg; 1998 Jan; 33(1):112-4. PubMed ID: 9473113 [TBL] [Abstract][Full Text] [Related]
22. Serum concentration of N-terminal procollagen peptide of collagen type III in schistosomal liver fibrosis. el-Mohandes M; Hassanein H; el-Badrawy N; Voss B; Gerlach U Exp Mol Pathol; 1987 Jun; 46(3):383-90. PubMed ID: 3109933 [TBL] [Abstract][Full Text] [Related]
23. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase. Kuutti-Savolainen ER; Risteli J; Miettinen TA; Kivirikko KI Eur J Clin Invest; 1979 Feb; 9(1):89-95. PubMed ID: 222594 [No Abstract] [Full Text] [Related]
24. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases. Lin DY; Chu CM; Sheen IS; Liaw YF Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112 [TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of serum collagen type IV in diagnosing liver fibrosis]. Feng X; Shen D; Wang J Zhonghua Nei Ke Za Zhi; 1995 Jul; 34(7):439-42. PubMed ID: 8556921 [TBL] [Abstract][Full Text] [Related]
26. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Murawaki Y; Ikuta Y; Koda M; Kawasaki H Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217 [TBL] [Abstract][Full Text] [Related]
27. [Diagnostic value of five serum markers for liver fibrosis]. Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388 [TBL] [Abstract][Full Text] [Related]
28. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Shahin M; Schuppan D; Waldherr R; Risteli J; Risteli L; Savolainen ER; Oesterling C; Abdel Rahman HM; el Sahly AM; Abdel Razek SM Hepatology; 1992 Apr; 15(4):637-44. PubMed ID: 1551641 [TBL] [Abstract][Full Text] [Related]
29. Three serum markers of collagen biosynthesis in Nigerians with cirrhosis and various infectious diseases. Bolarin DM; Savolainen ER; Kivirikko KI Eur J Clin Invest; 1984 Apr; 14(2):90-5. PubMed ID: 6329766 [TBL] [Abstract][Full Text] [Related]
31. [The relationship between the levels of serum fibrosis marks and morphometric quantitative measurement of hepatic histological fibrosis]. Xie S; Yao J; Zheng S; Yao C; Zheng R Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):203-5. PubMed ID: 10951617 [TBL] [Abstract][Full Text] [Related]
32. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B]. Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis. Ji X; Li S; Kong X; Xu G; Chen J; Dai X Chin Med J (Engl); 1997 Mar; 110(3):198-201. PubMed ID: 9594340 [TBL] [Abstract][Full Text] [Related]
34. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Bentsen KD; Horn T; Risteli J; Risteli L; Engström-Laurent A; Hørslev-Petersen K; Lorenzen I Liver; 1987 Dec; 7(6):339-46. PubMed ID: 3437796 [TBL] [Abstract][Full Text] [Related]
35. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C. Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209 [TBL] [Abstract][Full Text] [Related]
36. Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis. Takase S; Takada A; Yasuhara M; Sato H; Matsuda Y Gastroenterol Jpn; 1988 Dec; 23(6):639-45. PubMed ID: 2851477 [TBL] [Abstract][Full Text] [Related]
37. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis. Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863 [TBL] [Abstract][Full Text] [Related]
38. [Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance]. Xie J; OuYang K; Su T Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):93-6. PubMed ID: 10681810 [TBL] [Abstract][Full Text] [Related]
39. [Accurate diagnosis of stages of hepatic fibrosis by measuring levels of serum hyaluronic acid, procollagen type III, and collagen type IV]. Xie S; Yao J; Zheng R; Peng X; Gao Z Zhonghua Gan Zang Bing Za Zhi; 2001 Dec; 9(6):334-6. PubMed ID: 11782298 [TBL] [Abstract][Full Text] [Related]
40. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis. Bolarin DM; Andy JJ Ann Clin Res; 1983 Jun; 15(3):123-7. PubMed ID: 6314867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]